Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rezolve AA: Rezpegaldesleukin in Severe to Very Severe Alopecia Areata
NCT06340360Phase 2Completed
- Sponsor
- Nektar Therapeutics
- Start
- Apr 2024
- Primary completion
- Nov 2025
- Modality
- Biologic, rProtein (Recombinant Protein), Polyethylene glycol conjugate
- Countries
- 3
01
Overview
A Phase 2 trial of rezpegaldesleukin in alopecia areata, sponsored by Nektar Therapeutics. Started Apr 2024; status: completed.
02
Drugs
rezpegaldesleukin
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT06340360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06340360.